Statens Serum Institut

Copenhagen, Denmark Founded: 1902 • Age: 124 yrs Acquired By J Pharma Holding
Provider of scuba diving services and PADI instruction

About Statens Serum Institut

Statens Serum Institut is a company based in Copenhagen (Denmark) founded in 1902, and was acquired by J Pharma Holding in March 2017. Provider of scuba diving services and PADI instruction. The company has 922 employees. Its chief executive, as recorded, is Niels Strandberg Pedersen. Its website ssi.dk draws about 154 thousand monthly visits. Statens Serum Institut offers products and services including Vaccinations and Diagnostics.

Company details

Founded in 1902 and based in Copenhagen, Denmark, Statens Serum Institut operates in the scuba diving sector. Dives are conducted at wreck and reef sites, with instruction provided through PADI, DSAT, and IDCIESSI programs, including extended range courses. Equipment rental and boat trips to dive locations are available. Services cater to beginners and experienced divers alike, under the leadership of CEO Niels Strandberg Pedersen.

  • Headquarters Copenhagen, Denmark
  • Employees 922
  • Stage Acquired
  • Website category Health
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ssi.dk
  • Social LinkedIn X
  • Acquired by J Pharma Holding (Mar 2017)
  • Legal Name Statens Serum Institut
Key Metrics

Products & Services of Statens Serum Institut

Statens Serum Institut offers a comprehensive portfolio of products and services, including Vaccinations and Diagnostics.

Vaccinations
Health Services

Vaccinations are provided for various infectious diseases as part of public health initiatives

Diagnostics
Medical Services

Diagnostic services are offered for infections and related health conditions

Funding Insights of Statens Serum Institut

  • Total Rounds 5
  • Last Round Grant β€” $263,148
  • Investors Count 2

All 5 funding rounds of Statens Serum Institut with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2017$263,148Grant––
May 2015$656,376Grant––
Jan 2014Grant––
May 2012$588,531Grant––
Mar 2010Grant––
Valuation history

4 investors in total: 4 institutional.

Investors in Statens Serum Institut

Statens Serum Institut has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, AJ Pharma Holding and Adelis Equity.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Adelis Equity is engaged in growing Nordic businesses through partnerships.
adelisequity.comStockholm, Sweden
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
hhs.gov
AJ Pharma Holding is focused on healthcare investment and technology.
2012ajpharmaholding.comKuala Lumpur, Malaysia
Premium access

Investor details for Statens Serum Institut

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Statens Serum Institut

13 people are tracked at Statens Serum Institut (6 in leadership, 7 in team); the tracked headcount is 922.

NameRoleGroup
Niels Strandberg Pedersen
CEOLeadership
Doug Sproule
COO Sustainable Solutions InternationalLeadership
Gitte Stawski
Quality Control DirectorLeadership
Heather Boyd
Senior Researcher (epidemiologist) And Head Of SectionLeadership
Gabriel Pedersen
Head Of Section, Adjuvant ResearchLeadership
Michael Christiansen
Research Director, Dept For Congenital DisordersLeadership
Bent Hygum
Funktionschef QATeam
Jesper Larsen
Senior ScientistTeam
Ian Skovsted
Research ScientistTeam
Morten Rasmussen
Unit LeaderTeam
Peter Nyborg Rasmussen
AfdelingschefTeam
Rafah G. Nagras
Delegated Qp, Batch ReleaseTeam
Lasse S. Vestergaard
Senior Medical Officer (overlæge), Team Lead, Division Of Infectious Diseases PreparednessTeam
Premium access

Complete people profiles for Statens Serum Institut

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Statens Serum Institut

5 dated milestones of Statens Serum Institut across 115 years, from founding to its latest funding, stage changes and deals.

  1. Founded Statens Serum Institut is founded.
  2. Funding First funding round.
  3. Exit Acquired by Adelis Equity Partners.
  4. Funding Latest funding round, Grant, of $263K.
  5. Exit Acquired by J Pharma Holding.

Web traffic of Statens Serum Institut

The website of Statens Serum Institut (ssi.dk) receives about 154.1K visits a month and ranks #231,398 among all websites worldwide, #7,671 in Health.

  • Monthly visits
    154.1K

    ▼ 15.6% vs previous month

  • Unique visitors
    95.5K

    per month

  • Global rank
    #231,398

    among all websites

  • Category rank
    #7,671

    Health · Health

Similar websites

Websites whose visitors overlap most with Statens Serum Institut. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sundhed.dk
100%
2.4M#23,667View details
sst.dk
67%
344.7K#128,945View details
sikkerrejse.dk
66%
107.2K#286,164View details
rigshospitalet.dk
64%
#257,155View details
sundhedsstyrelsen.dk
sundhedsstyrelsen.dk
57%
#8,688,646–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Statens Serum Institut

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Statens Serum Institut

Premium access

Complete news archive for Statens Serum Institut

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Statens Serum Institut

Statens Serum Institut was founded in 1902 and raised its 1st funding round 108 years after it was founded.

Statens Serum Institut is headquartered in Copenhagen, Denmark.

Niels Strandberg Pedersen is the CEO of Statens Serum Institut, as recorded in our data.

Statens Serum Institut has 922 employees.

Founded in 1902 and based in Copenhagen, Denmark, Statens Serum Institut operates in the scuba diving sector. Dives are conducted at wreck and reef sites, with instruction provided through PADI, DSAT, and IDCIESSI programs, including extended range courses. Equipment rental and boat trips to dive locations are available. Services cater to beginners and experienced divers alike, under the leadership of CEO Niels Strandberg Pedersen.

Statens Serum Institut offers Vaccinations and Diagnostics.

Statens Serum Institut has 4 investors. Key investors include European Union, AJ Pharma Holding, Adelis Equity, and HHS.

Statens Serum Institut operates through Statens Serum Institut.

Yes. Statens Serum Institut was acquired by J Pharma Holding in March 2017.

The website of Statens Serum Institut receives about 154 thousand visits a month and ranks #231,398 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available